PT  - JOURNAL ARTICLE
AU  - Seale, Holly
AU  - Harris-Roxas, Ben
AU  - Heywood, Anita
AU  - Abdi, Ikram
AU  - Mahimbo, Abela
AU  - Woodland, Lisa
AU  - Waller, Emily
TI  - “It’s no use saying it in English”: A qualitative study exploring community leaders’ perceptions of the challenges and opportunities with translating and interpreting COVID-19 related public health messaging to reach ethnic minorities in Australia
AID  - 10.1101/2023.03.23.23287618
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.23.23287618
4099  - http://medrxiv.org/content/early/2023/03/24/2023.03.23.23287618.short
4100  - http://medrxiv.org/content/early/2023/03/24/2023.03.23.23287618.full
AB  - Background The Australian Government implemented a range of public health response strategies and communication approaches to reduce the spread of COVID-19; however, concerns have been raised around a failure to consider culturally and linguistically diverse (CaLD) communities sufficiently in these processes. This research aimed to understand the factors that have impacted COVID-19 communication and engagement efforts during the pandemic from the perspective of key CaLD community stakeholders and community members. A further aim was to understand the processes that could be adopted to support future communication strategies, including the promotion of pandemic-related vaccines.Approach This study included 29 key informant interviews with community and faith-based leaders in New South Wales, Australia.Results The overwhelming message from community leaders was a sense of shared responsibility between their organisations and the government in communicating pertinent and accurate COVID-19 related information to CaLD communities. They expressed a sense of duty to keep their community members safe. While acknowledging this shared responsibility, community leaders and others shouldered significant costs related to resources and time that need to be acknowledged by governments in preparing for future disease outbreaks. They felt that governments should consider: 1) improving communication between governments and CaLD organisations; 2) responding to the specific CaLD needs with greater agility; 3) foregrounding social media in their communication strategy; 4) reinvesting in local public health units to know their population; 5) investing in a health ambassadors model program; 6) preparing a hybrid model of translators/interpreters to fill the gap; and, 7) reimagining vaccine information campaigns to better target CaLD communities.Conclusion Given the technical details about the COVID-19 virus conveyed in government information campaigns and the media, ensuring the most vulnerable populations, including people from CaLD backgrounds, access clear, concise and timely public health messaging from both governments and community organisations requires further attention.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThe NSW Multicultural Health Communication Unit supported this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Research Ethics Advisory Panel at the University of New South Wales reviewed and approved this study (HC200776). All of the methods used in this study were performed in accordance with the relevant guidelines, outlined by The National Statement on Ethical Conduct in Human Research, published by the Australian Government. Informed verbal consent was collected from all participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets generated during and/or analysed during the current study are not publicly available due to the sensitive nature of the topic raised during the interviews, but are available from the corresponding author upon reasonable request.